1-(3-Chlorophenyl)-6-methyl-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one

Catalog No. :
ACTGYI621
CAS No. :
1097095-35-6
Molecular Formula :
C12H9ClN4O
Molecular Weight :
260.68

IUPAC Name:1-(3-chlorophenyl)-6-methyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one

1-(3-Chlorophenyl)-6-methyl-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$187.00Login to see priceInquiryInquiry
250mg98%$380.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Chlorophenyl)-6-methyl-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one
IUPAC Name1-(3-chlorophenyl)-6-methyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
MDL No.MFCD11544235
Molecular FormulaC12H9ClN4O
Molecular Weight260.68
SMILESO=C1C2=C(N(C3=CC=CC(Cl)=C3)N=C2)N=C(C)N1
InChI KeyFGNFLLALMJCHAE-UHFFFAOYSA-N
Synonym1-(3-Chlorophenyl)-6-methyl-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one;4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1-(3-chlorophenyl)-1,5-dihydro-6-methyl-
CAS No.1097095-35-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACTGYI621 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGYI621 route product structure diagram
    ACTGYI6211097095-35-6
Inquiry

2. ACTGYI621 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGNPY406 route compound structure diagram
    ACGNPY40630129-57-8 In Stock
  2. Plus
  3. ACNSOE016 route compound structure diagram
    ACNSOE01663503-60-6 In Stock
  4. Then
  5. ACTGYI621 route product structure diagram
    ACTGYI6211097095-35-6
Inquiry

Comments (0)